ArticleClinical epigenetics2025
Newborn mitochondrial DNA copy number is associated with changes to DNA methylation that persist into childhood and are associated with cognitive development.
Article in Clinical epigenetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cord Blood Mitochondrial DNA Copy Number and Physical Growth in Infancy and Toddlerhood: A Birth Cohort Analysis.Children (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
BACKGROUND/
objectivesMitochondrial-nuclear crosstalk is critical for cell function, and nuclear DNA methylation (DNAm) may regulate this process. Mitochondria maintain an extranuclear genome, and mitochondrial DNA copy number (mtDNA-CN) has been previously associated with DNAm. However, there is little information on this relationship in children, whose brains are particularly vulnerable to energetic perturbations during development. Our objectives were to (1) characterize associations of mtDNA-CN with nuclear DNAm at birth; (2) determine their persistence into childhood; and (3) investigate associations in relation to neurodevelopment.
methodsWe quantified mtDNA-CN with qRT-PCR and DNAm with the MethylationEPIC BeadChip array in umbilical cord leukocytes (N = 422) in newborns from the PROGRESS birth cohort in Mexico City (2007-2011). At the 48-month visit, we measured DNAm in peripheral blood leukocytes (N = 177) and assessed the McCarthy Scales of Children's Abilities (N = 290). We performed an epigenome-wide association study (EWAS) with cord mtDNA-CN in mitochondrially relevant genes (23,261 CpG sites) and across the genome (745,691 sites). We determined if our results persisted until childhood and were associated with cognitive scales. The findings were replicated in a US-based cohort (N = 130).
resultsWe observed 11 and 165 differentially methylated positions (DMPs) in mitochondria-related nuclear genes and across the genome, respectively, after correction for multiple comparisons. In mitochondrial genes, two significant DMPs mapped to PRELID3A and a DMP in the promoter region of SLC25A24 replicated in our external cohort. At 48 months of age, 17 of 165 DMPs remained associated with cord mtDNA-CN, 12 were associated with child memory scales, and associations with 17 replicated in our external cohort. Several positions mapped to genes in immune activation and development.
conclusionsIn newborns, mtDNA-CN was associated with DNAm in mitochondria-related genes and throughout the genome, several of which remained associated in childhood, were associated with child memory scales, and were replicated in a US-based cohort. These findings open new avenues for future targets for children's health and disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.